Ardelyx (ARDX) Accumulated Expenses (2013 - 2026)
Ardelyx (ARDX) posted Accumulated Expenses of $9.4 million for Q1 2026, down 50.9% on a QoQ basis from $19.1 million in Q4 2025, and up 30.89% year-over-year from $7.2 million in Q1 2025.
Ardelyx (ARDX) Accumulated Expenses (2013 - 2026) Analysis & Trends
Ardelyx's Accumulated Expenses history runs 14 years deep, the most recent figure standing at $9.4 million for Q1 2026.
- Quarterly Accumulated Expenses rose 30.89% year-over-year to $9.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.4 million (up 30.89% YoY) and the FY2025 annual result came in at $19.1 million, up 27.9% from the prior year.
- Accumulated Expenses was $9.4 million for Q1 2026 at Ardelyx, down from $19.1 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $41.9 million in Q3 2025 and bottomed at $6.7 million in Q1 2024.
- A 5-year average of $16.1 million and a median of $12.4 million in 2022 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2022 — Accumulated Expenses slumped 39.82% — and 2025, when it surged 289.76%.
- Ardelyx's Accumulated Expenses stood at $12.4 million in 2022, then grew by 1.75% to $12.6 million in 2023, then grew by 18.6% to $14.9 million in 2024, then grew by 27.9% to $19.1 million in 2025, then plunged by 50.9% to $9.4 million in 2026.
- Business Quant data shows ARDX's Accumulated Expenses at $9.4 million in Q1 2026, $19.1 million in Q4 2025, and $41.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.38 Mn |
| Dec 31, 2025 | 19.11 Mn |
| Sep 30, 2025 | 41.93 Mn |
| Jun 30, 2025 | 40.76 Mn |
| Mar 31, 2025 | 7.17 Mn |
| Dec 31, 2024 | 14.94 Mn |
| Sep 30, 2024 | 33.30 Mn |
| Jun 30, 2024 | 10.46 Mn |
| Mar 31, 2024 | 6.73 Mn |
| Dec 31, 2023 | 12.60 Mn |
| Sep 30, 2023 | 19.04 Mn |
| Jun 30, 2023 | 12.40 Mn |
| Mar 31, 2023 | 11.05 Mn |
| Dec 31, 2022 | 12.38 Mn |
| Sep 30, 2022 | 7.34 Mn |
| Jun 30, 2022 | 7.94 Mn |
| Mar 31, 2022 | 6.78 Mn |
| Dec 31, 2021 | 7.37 Mn |
| Sep 30, 2021 | 11.37 Mn |
| Jun 30, 2021 | 5.94 Mn |